PeptiDream (TSE:4587) Loans Receivable: 円0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4587 PeptiDream Inc TSE:4587
64 GF Score
Price 円1,007.00
GF Value 円1,013.27
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is PeptiDream Loans Receivable?

PeptiDream TSE:4587 +1.49% 64 Loans Receivable is 円0 Mil as of Jun. 2026. GuruFocus rates TSE:4587 with a GF Score™ of 64/100 and a GF Value™ of 円1,013.27 (Fairly Valued). The stock has 4 warning signs investors should review.

PeptiDream's Loans Receivable for the quarter that ended in Jun. 2026 was 円0 Mil.

PeptiDream Loans Receivable Historical Data

* Premium members only.

The historical data trend for PeptiDream's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PeptiDream Loans Receivable Chart

PeptiDream Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PeptiDream Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4587
64GF Score
PeptiDream Inc TSE:4587
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PeptiDream Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of 円0 Mil mean?
PeptiDream (TSE:4587) has a Loans Receivable of 円0 Mil as of Jun. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on PeptiDream and its competitors.
Is PeptiDream's Loans Receivable too high?
PeptiDream's current Loans Receivable is 円0 Mil. Overall, PeptiDream has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PeptiDream's Loans Receivable compare to VRTX and REGN?
PeptiDream's Loans Receivable of 円0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Biotechnology company?
A good Loans Receivable depends on the Biotechnology industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on PeptiDream and its competitors. PeptiDream's current Loans Receivable is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PeptiDream stock overvalued right now?
Based on GuruFocus' analysis, PeptiDream (TSE:4587) is currently considered Fairly Valued. The stock's GF Value™ is 円1,013.27, compared to a current price of 円1,007.00 — trading 0.6% below its estimated fair value. The current Loans Receivable is 円0 Mil. PeptiDream's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For PeptiDream (TSE:4587), the current Loans Receivable is 円0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PeptiDream (TSE:4587) Overvalued in 2026?

Based on GuruFocus' analysis, PeptiDream stock appears to be undervalued. The current stock price of 円1,007.00 is trading 0.6% below its estimated GF Value™ of 円1,013.27. GuruFocus considers PeptiDream to be Fairly Valued.

Key valuation signals for TSE:4587:

  • Loans Receivable: 円0 Mil
  • GF Value™: 円1,013.27 vs. price of 円1,007.00 (0.6% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the TSE:4587 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PeptiDream Business Description

Other Exchanges PPTDF:USA
Address 3-25-23 Tonomachi, Kawasaki-ku, Kanagawa Prefecture, Kawasaki, JPN, 210-0821
PeptiDream Inc is engaged in the drug discovery and development business. The group utilizes PDPS, its proprietary drug discovery and development platform system, for drug discovery and development, and it conducts radiopharmaceutical business through a wholly owned subsidiary and is involved in the research, development, and manufacturing of pharmaceuticals, etc. Its reportable segments are Drug discovery and development business and Radiopharmaceutical business.
64GF Score

Get the complete analysis for TSE:4587

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,007.00
Price
円1,013.27
GF Value